ScinoPharm Taiwan Ltd
TWSE:1789

Watchlist Manager
ScinoPharm Taiwan Ltd Logo
ScinoPharm Taiwan Ltd
TWSE:1789
Watchlist
Price: 22.55 TWD 0.89%
Market Cap: 17.8B TWD
Have any thoughts about
ScinoPharm Taiwan Ltd?
Write Note

ScinoPharm Taiwan Ltd
Effect of Foreign Exchange Rates

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

ScinoPharm Taiwan Ltd
Effect of Foreign Exchange Rates Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Effect of Foreign Exchange Rates CAGR 3Y CAGR 5Y CAGR 10Y
ScinoPharm Taiwan Ltd
TWSE:1789
Effect of Foreign Exchange Rates
NT$10.8m
CAGR 3-Years
28%
CAGR 5-Years
-8%
CAGR 10-Years
N/A
Y
YungShin Global Holding Corp
TWSE:3705
Effect of Foreign Exchange Rates
-NT$2.6m
CAGR 3-Years
66%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Formosa Laboratories Inc
TWSE:4746
Effect of Foreign Exchange Rates
NT$6.5m
CAGR 3-Years
N/A
CAGR 5-Years
77%
CAGR 10-Years
N/A
S
SCI Pharmtech Inc
TWSE:4119
Effect of Foreign Exchange Rates
N/A
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Lotus Pharmaceutical Co Ltd
TWSE:1795
Effect of Foreign Exchange Rates
NT$36.1m
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
30%
Standard Chem & Pharm Co Ltd
TWSE:1720
Effect of Foreign Exchange Rates
NT$8.1m
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
0%
No Stocks Found

ScinoPharm Taiwan Ltd
Glance View

Market Cap
17.8B TWD
Industry
Pharmaceuticals

ScinoPharm Taiwan Ltd. engages in the research, development, manufacturing, and sales of active pharmaceutical ingredients and injections. The company is headquartered in Tainan, Tainan. The company went IPO on 2010-10-29. The main products include active pharmaceutical ingredients, protein drugs, oligonucleotides, peptides, injection preparations, new small molecule drugs and other chemical raw materials. The firm is also engaged in the provision of consulting and biotechnology services for related products, the international trading of products, as well as the provision of customized full-process services such as chemical molecular component synthesis, process development and commercial mass production. The firm operates within the domestic market and to overseas markets, including the Americas, Europe, Australia and Asia.

Intrinsic Value
17.52 TWD
Overvaluation 22%
Intrinsic Value
Price

See Also

What is ScinoPharm Taiwan Ltd's Effect of Foreign Exchange Rates?
Effect of Foreign Exchange Rates
10.8m TWD

Based on the financial report for Sep 30, 2024, ScinoPharm Taiwan Ltd's Effect of Foreign Exchange Rates amounts to 10.8m TWD.

What is ScinoPharm Taiwan Ltd's Effect of Foreign Exchange Rates growth rate?
Effect of Foreign Exchange Rates CAGR 5Y
-8%

The average annual Effect of Foreign Exchange Rates growth rates for ScinoPharm Taiwan Ltd have been 28% over the past three years , -8% over the past five years .

Back to Top